Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
DrBL: One drives the other
NAION is rare: doctors diagnose about 6,000 new cases of it every year in the United States, which has a population of 340 million people
While the bank had expected clinical trial success in this indication, he said the drug is substantially exceeding expectations. Read the article in MedCity News from Frank Vinluan: To view or add a comment, sign in Unicycive Therapeutics (Nasdaq: UNCY) announced that the FDA has accepted the resubmission of its New Drug Application (NDA) for oxylanthanum carbonate (OLC), the companys investigational oral phosphate binder for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis
De Block CE, Van Gaal LF
US$ 27.11
US$ 23.68
US$ 24.09
US$ 22.58
US$ 22.16
